---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-393322"
form_type: "8-K"
ticker: "BBNX"
cik: "0001674632"
company_name: "Beta Bionics, Inc."
filed_at: "2026-09-16T22:24:10+00:00"
generated_at: "2026-09-17T10:06:06.829343+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Beta Bionics prices $150M public offering of common stock and pre-funded warrants

## Summary
- Priced 7,652,175 common shares at $17.25 and 1,043,484 pre-funded warrants at $17.2499 per share.
- Gross proceeds expected ~$150.0M; closing expected Sept 17, 2026.
- Underwriters granted 30-day option to purchase up to 1,304,348 additional shares.
- Proceeds for general corporate purposes including Mint commercialization, manufacturing expansion, R&D.
- J.P. Morgan, Piper Sandler, Wells Fargo, and Leerink act as joint book-running managers.

## SEC filing metadata
- accession: 0001193125-26-393322
- form_type: 8-K
- ticker: BBNX
- cik: 0001674632
- company_name: Beta Bionics, Inc.
- filed_at: 2026-09-16T22:24:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674632/000119312526393322/0001193125-26-393322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674632/000119312526393322/d178069d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-393322
- JSON: https://secwatch.observer/filing/0001193125-26-393322.json
- Plain text: https://secwatch.observer/filing/0001193125-26-393322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.